Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2012-06-07 Capital/Financing Update
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
FAIRMOUNT FIVE CONVERSION
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 7, 2012. It reports a specific event: the conversion of convertible preferred shares into common shares, resulting in a change in the number of common shares outstanding. There are no financial statements or exhibits attached, and the document mainly serves as an announcement of a capital structure change. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is short (2794 characters), but it is not merely announcing the publication of a report; it is itself the report of the event. Therefore, the correct classification is CAP with high confidence.
2012-06-07 English
FAIRMOUNT FINAL TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated May 4, 2012, by Ecology Coatings, Inc. The content focuses on the unregistered sale of equity securities, specifically the final tranche of a convertible preferred shares purchase by Fairmount Five, LLC. There are no financial statements or exhibits included, and the report primarily serves to disclose a capital financing event. This matches the description of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes. The document length is 3373 characters, which is typical for an 8-K report and not a full annual or quarterly report. Therefore, the correct classification is CAP with high confidence.
2012-06-04 English
FORM 8-K CROCKETT RESIGNATION
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated May 21, 2012, reporting the resignation of the CEO, Robert Crockett, and related employment agreement issues. The key content is about a change in senior management, specifically the departure of an officer. There are no financial statements or detailed financial data, nor is this an announcement of a report publication. The document fits the category of Board/Management Information (MANG) as it announces changes in the company's senior management.
2012-05-21 English
2ND QUARTER FY 2012 10-Q
Interim / Quarterly Report Q2 2012
2012-05-15 English
FAIRMOUNT TRANCHE #22
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content specifically discusses an unregistered sale of equity securities (Convertible Preferred Shares) and references prior filings. There are no financial statements or comprehensive financial data included, and the document is relatively short (3271 characters). It is not an annual or quarterly report, nor is it a presentation or earnings release. The primary focus is on a capital transaction update. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2012-05-01 English
FAIRMOUNT FIVE TRANCHE APRIL 13, 2012
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The content specifically details an unregistered sale of equity securities (Convertible Preferred Shares) and references the Securities Act exemption. There are no financial statements or comprehensive financial data presented, and the document is relatively short (3277 characters). This type of filing is best classified as a Capital/Financing Update (CAP) because it reports on a financing transaction involving equity securities. It is not an Annual Report, Earnings Release, or other report types. Therefore, the correct classification is CAP with high confidence.
2012-04-17 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.